Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| VOR | VOR BIOPHARMA INC | $785.15M | 54,185,877 | 74.65% | 23.50% | Net Selling | Net Selling | ||
| VKTX | VIKING THERAPEUTICS INC | $3.53B | 116,105,643 | 63.04% | 8.85% | Net Selling | |||
| CCCC | C4 THERAPEUTICS INC | $458.85M | 110,567,222 | 76.42% | 18.10% | Net Selling | Net Buying | ||
| AKTS | AKTIS ONCOLOGY INC | $1.29B | 53,404,618 | 52.35% | 47.65% | Net Buying | |||
| PEPG | PEPGEN INC | $123.81M | 69,169,215 | 80.68% | 9.74% | Net Buying | Net Selling | ||
| RACE | FERRARI NV | $63.92B | 176,514,000 | 33.28% | 0.00% | ||||
| CRVS | CORVUS PHARMACEUTICALS INC | $1.00B | 84,090,424 | 68.16% | 31.84% | Net Buying | Net Buying | ||
| BNTX | BIONTECH SE | $21.81B | 239,970,804 | 19.80% | 17.34% | Net Selling | Net Selling | ||
| SAIL | SAILPOINT INC | $7.56B | 567,182,997 | 52.78% | 47.22% | Net Selling | Net Selling | ||
| NEXN | NEXXEN INTERNATIONAL LTD | $248.11M | 57,700,000 | 63.98% | 2.44% | Net Selling | Net Selling | ||
| ARCT | ARCTURUS THERAPEUTICS HOLDINGS INC | $214.03M | 28,423,069 | 85.46% | 12.98% | Net Buying | |||
| HIVE | HIVE DIGITAL TECHNOLOGIES LTD | $1.14B | 267,430,821 | 30.52% | 0.78% | Net Selling | Net Selling | ||
| EQT | EQT CORP | $31.72B | 625,478,000 | 88.26% | 11.74% | Net Selling | Net Selling | ||
| REAX | REAL BROKERAGE INC | $370.44M | 210,478,399 | 46.37% | 0.00% | ||||
| GT | GOODYEAR TIRE & RUBBER CO | $1.78B | 287,438,631 | 94.05% | 1.80% | Net Selling | Net Selling | ||
| BBOT | BRIDGEBIO ONCOLOGY THERAPEUTICS INC | $605.61M | 80,107,104 | 62.76% | 37.24% | Net Buying | Net Selling | ||
| SLDB | SOLID BIOSCIENCES INC | $820.09M | 98,449,606 | 60.19% | 39.81% | Net Selling | |||
| PCVX | VAXCYTE INC | $7.43B | 144,397,682 | 89.00% | 11.00% | Net Selling | Net Selling | ||
| CGEM | CULLINAN THERAPEUTICS INC | $923.71M | 61,458,046 | 57.24% | 42.76% | Net Buying | Net Selling | ||
| ORIC | ORIC PHARMACEUTICALS INC | $878.86M | 103,517,562 | 84.79% | 15.21% | Net Selling | |||
| XE | X-ENERGY INC | $6.20B | 287,458,734 | 0.00% | 36.79% | Net Buying | Net Buying | ||
| CATX | PERSPECTIVE THERAPEUTICS INC | $336.44M | 114,046,197 | 41.47% | 58.53% | Net Buying |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.